Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Musculoskeletal Disorders
Published in: BMC Musculoskeletal Disorders 1/2009

Open Access 01-12-2009 | Research article

Myoblast sensitivity and fibroblast insensitivity to osteogenic conversion by BMP-2 correlates with the expression of Bmpr-1a

Authors: Renjing Liu, Samantha L Ginn, Monkol Lek, Kathryn N North, Ian E Alexander, David G Little, Aaron Schindeler

Published in: BMC Musculoskeletal Disorders | Issue 1/2009

Login to get access

Abstract

Background

Osteoblasts are considered to primarily arise from osseous progenitors within the periosteum or bone marrow. We have speculated that cells from local soft tissues may also take on an osteogenic phenotype. Myoblasts are known to adopt a bone gene program upon treatment with the osteogenic bone morphogenetic proteins (BMP-2,-4,-6,-7,-9), but their osteogenic capacity relative to other progenitor types is unclear. We further hypothesized that the sensitivity of cells to BMP-2 would correlate with BMP receptor expression.

Methods

We directly compared the BMP-2 sensitivity of myoblastic murine cell lines and primary cells with osteoprogenitors from osseous tissues and fibroblasts. Fibroblasts forced to undergo myogenic conversion by transduction with a MyoD-expressing lentiviral vector (LV-MyoD) were also examined. Outcome measures included alkaline phosphatase expression, matrix mineralization, and expression of osteogenic genes (alkaline phosphatase, osteocalcin and bone morphogenetic protein receptor-1A) as measured by quantitative PCR.

Results

BMP-2 induced a rapid and robust osteogenic response in myoblasts and osteoprogenitors, but not in fibroblasts. Myoblasts and osteoprogenitors grown in osteogenic media rapidly upregulated Bmpr-1a expression. Chronic BMP-2 treatment resulted in peak Bmpr-1a expression at day 6 before declining, suggestive of a negative feedback mechanism. In contrast, fibroblasts expressed low levels of Bmpr-1a that was only weakly up-regulated by BMP-2 treatment. Bioinformatics analysis confirmed the presence of myogenic responsive elements in the proximal promoter region of human and murine BMPR-1A/Bmpr-1a. Forced myogenic gene expression in fibroblasts was associated with a significant increase in Bmpr-1a expression and a synergistic increase in the osteogenic response to BMP-2.

Conclusion

These data demonstrate the osteogenic sensitivity of muscle progenitors and provide a mechanistic insight into the variable response of different cell lineages to BMP-2.
Appendix
Available only for authorised users
Literature
1.
Karsenty G, Ducy P, Starbuck M, Priemel M, Shen J, Geoffroy V, Amling M: Cbfa1 as a regulator of osteoblast differentiation and function. Bone. 1999, 25: 107-8. 10.1016/S8756-3282(99)00111-8.CrossRefPubMed
2.
Canalis E, Economides AN, Gazzerro E: Bone morphogenetic proteins, their antagonists, and the skeleton. Endocrine Reviews. 2003, 24: 218-35. 10.1210/er.2002-0023.CrossRefPubMed
3.
Kawabata M, Imamura T, Miyazono K: Signal transduction by bone morphogenetic proteins. Cytokine & Growth Factor Reviews. 1998, 9: 49-61. 10.1016/S1359-6101(97)00036-1.CrossRef
4.
Miyazono K, Maeda S, Imamura T: BMP receptor signaling: transcriptional targets, regulation of signals, and signaling cross-talk. Cytokine & Growth Factor Reviews. 2005, 16: 251-63. 10.1016/j.cytogfr.2005.01.009.CrossRef
5.
Koenig BB, Cook JS, Wolsing DH, Ting J, Tiesman JP, Correa PE, Olson CA, Pecquet AL, Ventura F, Grant RA: Characterization and cloning of a receptor for BMP-2 and BMP-4 from NIH 3T3 cells. Mol Cell Biol. 1994, 14: 5961-74.CrossRefPubMedPubMedCentral
6.
ten Dijke P, Yamashita H, Sampath TK, Reddi AH, Estevez M, Riddle DL, Ichijo H, Heldin CH, Miyazono K: Identification of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4. Journal of Biological Chemistry. 1994, 269: 16985-8.PubMed
7.
Gerstenfeld LC, Cullinane DM, Barnes GL, Graves DT, Einhorn TA: Fracture healing as a post-natal developmental process: molecular, spatial, and temporal aspects of its regulation. Journal of Cellular Biochemistry. 2003, 88: 873-84. 10.1002/jcb.10435.CrossRefPubMed
8.
Kugimiya F, Kawaguchi H, Kamekura S, Chikuda H, Ohba S, Yano F, Ogata N, Katagiri T, Harada Y, Azuma Y, Nakamura K, Chung UI: Involvement of endogenous bone morphogenetic protein (BMP) 2 and BMP6 in bone formation. Journal of Biological Chemistry. 2005, 280: 35705-12. 10.1074/jbc.M505166200.CrossRef
9.
Miura Y, Miura M, Gronthos S, Allen MR, Cao C, Uveges TE, Bi Y, Ehirchiou D, Kortesidis A, Shi S, Zhang L: Defective osteogenesis of the stromal stem cells predisposes CD18-null mice to osteoporosis. Proceedings of the National Academy of Sciences of the United States of America. 2005, 102: 14022-7. 10.1073/pnas.0409397102.CrossRefPubMedPubMedCentral
10.
Friedenstein AJ, Piatetzky-Shapiro II, Petrakova KV: Osteogenesis in transplants of bone marrow cells. Journal of Embryology & Experimental Morphology. 1966, 16: 381-90.
11.
Eghbali-Fatourechi GZ, Lamsam J, Fraser D, Nagel D, Riggs BL, Khosla S: Circulating osteoblast-lineage cells in humans. New England Journal of Medicine. 2005, 352: 1959-66. 10.1056/NEJMoa044264.CrossRefPubMed
12.
Otsuru S, Tamai K, Yamazaki T, Yoshikawa H, Kaneda Y: Bone marrow-derived osteoblast progenitor cells in circulating blood contribute to ectopic bone formation in mice. Biochemical & Biophysical Research Communications. 2007, 354: 453-8. 10.1016/j.bbrc.2006.12.226.CrossRef
13.
Schindeler A, Liu R, Little DG: The contribution of different cell lineages to bone repair: Exploring a role for muscle stem cells. Differentiation. 2009, 77: 12-8.CrossRefPubMed
14.
Rasko JE: Transdifferentiation: an attractive concept in search of evidence. Pathology. 2003, 35: 5-10.1080/0031302021000062253.PubMed
15.
Katagiri T, Yamaguchi A, Komaki M, Abe E, Takahashi N, Ikeda T, Rosen V, Wozney JM, Fujisawa-Sehara A, Suda T: Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. Journal of Cell Biology. 1994, 127: 1755-66. 10.1083/jcb.127.6.1755.CrossRefPubMed
16.
Yeh LC, Tsai AD, Lee JC: Osteogenic protein-1 (OP-1, BMP-7) induces osteoblastic cell differentiation of the pluripotent mesenchymal cell line C2C12. Journal of Cellular Biochemistry. 2002, 87: 292-304. 10.1002/jcb.10315.CrossRefPubMed
17.
Bossche Vanden L, Vanderstraeten G: Heterotopic ossification: a review. Journal of Rehabilitation Medicine. 2005, 37: 129-36. 10.1080/16501970510027628.CrossRef
18.
Wright V, Peng H, Usas A, Young B, Gearhart B, Cummins J, Huard J: BMP4-expressing muscle-derived stem cells differentiate into osteogenic lineage and improve bone healing in immunocompetent mice. Molecular Therapy: the Journal of the American Society of Gene Therapy. 2002, 6: 169-78.CrossRef
19.
Yu PB, Deng DY, Lai CS, Hong CC, Cuny GD, Bouxsein ML, Hong DW, McManus PM, Katagiri T, Sachidanandan C, Kamiya N, Fukuda T, Mishina Y, Peterson RT, Bloch KD: BMP type I receptor inhibition reduces heterotropic ossification. Nature Medicine. 2008, 14: 1363-9. 10.1038/nm.1888.CrossRefPubMedPubMedCentral
20.
Dellavalle A, Sampaolesi M, Tonlorenzi R, Tagliafico E, Sacchetti B, Perani L, Innocenzi A, Galvez BG, Messina G, Morosetti R, Li S, Belicchi M, Peretti G, Chamberlain JS, Wright WE, Torrente Y, Ferrari S, Bianco P, Cossu G: Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells. Nature Cell Biology. 2007, 9: 255-67. 10.1038/ncb1542.CrossRefPubMed
21.
Bosch P, Musgrave DS, Lee JY, Cummins J, Shuler T, Ghivizzani TC, Evans T, Robbins TD, Huard J: Osteoprogenitor cells within skeletal muscle. Journal of Orthopaedic Research. 2000, 18: 933-44. 10.1002/jor.1100180613.CrossRefPubMed
22.
Levy MM, Joyner CJ, Virdi AS, Reed A, Triffitt JT, Simpson AH, Kenwright J, Stein H, Francis MJ: Osteoprogenitor cells of mature human skeletal muscle tissue: an in vitro study. Bone. 2001, 29: 317-22. 10.1016/S8756-3282(01)00585-3.CrossRefPubMed
23.
Jortikka L, Laitinen M, Wiklund J, Lindholm TS, Marttinen A: Use of myoblasts in assaying the osteoinductivity of bone morphogenetic proteins. Life Sciences. 1998, 62: 2359-68. 10.1016/S0024-3205(98)00218-5.CrossRefPubMed
24.
Khouri RK, Brown DM, Koudsi B, Deune EG, Gilula LA, Cooley BC, Reddi AH: Repair of calvarial defects with flap tissue: role of bone morphogenetic proteins and competent responding tissues. Plastic & Reconstructive Surgery. 1996, 98: 103-9. 10.1097/00006534-199607000-00017.CrossRef
25.
Lee JY, Musgrave D, Pelinkovic D, Fukushima K, Cummins J, Usas A, Robbins P, Fu FH, Huard J: Effect of bone morphogenetic protein-2-expressing muscle-derived cells on healing of critical-sized bone defects in mice. Journal of Bone & Joint Surgery – American Volume. 2001, 83-A: 1032-9.
26.
Lee JY, Peng H, Usas A, Musgrave D, Cummins J, Pelinkovic D, Jankowski R, Ziran B, Robbins P, Huard J: Enhancement of bone healing based on ex vivo gene therapy using human muscle-derived cells expressing bone morphogenetic protein 2. Human Gene Therapy. 2002, 13: 1201-11. 10.1089/104303402320138989.CrossRefPubMed
27.
Musgrave DS, Bosch P, Lee JY, Pelinkovic D, Ghivizzani SC, Whalen J, Niyibizi C, Huard J: Ex vivo gene therapy to produce bone using different cell types. Clinical Orthopaedics & Related Research. 2000, 378: 290-305. 10.1097/00003086-200009000-00040.CrossRef
28.
Musgrave DS, Pruchnic R, Wright V, Bosch P, Ghivizzani SC, Robbins PD, Huard J: The effect of bone morphogenetic protein-2 expression on the early fate of skeletal muscle-derived cells. Bone. 2001, 28: 499-506. 10.1016/S8756-3282(01)00413-6.CrossRefPubMed
29.
Yamaguchi A, Katagiri T, Ikeda T: Recombinant human bone morphogenetic protein-2 stimulates osteoblastic maturation and inhibits myogenic differentiation in vitro. Journal of Cell Biology. 1991, 113: 681-7. 10.1083/jcb.113.3.681.CrossRefPubMed
30.
Komaki M, Asakura A, Rudnicki MA, Sodek J, Cheifetz S: MyoD enhances BMP7-induced osteogenic differentiation of myogenic cell cultures. Journal of Cell Science. 2004, 117: 1457-68. 10.1242/jcs.00965.CrossRefPubMed
31.
Hewitt J, Lu X, Gilbert L, Nanes MS: The muscle transcription factor MyoD promotes osteoblast differentiation by stimulation of the Osterix promoter. Endocrinology. 2008, 149: 3698-707. 10.1210/en.2007-1556.CrossRefPubMed
32.
Namiki M, Akiyama S, Katagiri T, Suzuki A, Ueno N, Yamaji N, Rosen V, Wozney JM, Suda T: A kinase domain-truncated type I receptor blocks bone morphogenetic protein-2-induced signal transduction in C2C12 myoblasts. Journal of Biological Chemistry. 1997, 272: 22046-52. 10.1074/jbc.272.35.22046.CrossRefPubMed
33.
Akiyama S, Katagiri T, Namiki M, Yamaji N, Yamamoto N, Miyama K, Shibuya H, Ueno N, Wozney JM, Suda T: Constitutively active BMP type I receptors transduce BMP-2 signals without the ligand in C2C12 myoblasts. Experimental Cell Research. 1997, 235: 362-9. 10.1006/excr.1997.3680.CrossRefPubMed
34.
Qu Z, Balkir L, van Deutekom JC, Robbins PD, Pruchnic R, Huard J: Development of approaches to improve cell survival in myoblast transfer therapy. Journal of Cell Biology. 1998, 142: 1257-67. 10.1083/jcb.142.5.1257.CrossRefPubMedPubMedCentral
35.
36.
Cartharius K, Frech K, Grote K, Klocke B, Haltmeier M, Klingenhoff A, Frisch M, Bayerlein M, Werner T: MatInspector and beyond: promoter analysis based on transcription factor binding sites. Bioinformatics. 2005, 21: 2933-42. 10.1093/bioinformatics/bti473.CrossRefPubMed
37.
Kizana E, Ginn SL, Allen DG, Ross DL, Alexander IE: Fibroblasts can be genetically modified to produce excitable cells capable of electrical coupling. Circulation. 2005, 111: 394-8. 10.1161/01.CIR.0000153812.64956.EF.CrossRefPubMed
38.
Byers BA, Pavlath GK, Murphy JM, Karsenty G, Garcia AJ: Cell-type-dependent up-regulation of in vitro mineralization after overexpression of the osteoblast-specific transcription factor Runx2/Cbfa1. Journal of Bone & Mineral Research. 2002, 17: 1931-44. 10.1359/jbmr.2002.17.11.1931.CrossRef
39.
Pakos EE, Ioannidis JP: Radiotherapy vs. nonsteroidal anti-inflammatory drugs for the prevention of heterotopic ossification after major hip procedures: a meta-analysis of randomized trials. International Journal of Radiation Oncology, Biology, Physics. 2004, 60: 888-95.CrossRefPubMed
40.
Rumi MN, Deol GS, Singapuri KP, Pellegrini VD: The origin of osteoprogenitor cells responsible for heterotopic ossification following hip surgery: an animal model in the rabbit. Journal of Orthopaedic Research. 2005, 23: 34-40. 10.1016/j.orthres.2004.05.003.CrossRefPubMed
41.
Peault B, Rudnicki M, Torrente Y, Cossu G, Tremblay JP, Partridge T, Gussoni E, Kunkel LM, Huard J: Stem and progenitor cells in skeletal muscle development, maintenance, and therapy. Molecular Therapy: the Journal of the American Society of Gene Therapy. 2007, 15: 867-77.CrossRef
42.
Dellavalle A, Sampaolesi M, Tonlorenzi R, Tagliafico E, Sacchetti B, Perani L, Innocenzi A, Galvez BG, Messina G, Morosetti R, Li S, Belicchi M, Peretti G, Chamberlain JS, Wright WE, Torrente Y, Ferrari S, Bianco P, Cossu G: Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells. Nature Cell Biology. 2007, 9: 255-67. 10.1038/ncb1542.CrossRefPubMed
43.
Cossu G, Bianco P: Mesoangioblasts–vascular progenitors for extravascular mesodermal tissues. Current Opinion in Genetics & Development. 2003, 13: 537-42. 10.1016/j.gde.2003.08.001.CrossRef
44.
Shore EM, Xu M, Feldman GJ, Fenstermacher DA, Cho TJ, Choi IH, Connor JM, Delai P, Glaser DL, LeMerrer M, Morhart R, Rogers JG, Smith R, Triffitt JT, Urtizberea JA, Zasloff MA, Brown MA, Kaplan FS: A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva. Nature Genetics. 2006, 38: 525-7. 10.1038/ng1783.CrossRefPubMed
45.
Lavery K, Swain P, Falb D, Alaoui-Ismaili MH: BMP-2/4 and BMP-6/7 differentially utilize cell surface receptors to induce osteoblastic differentiation of human bone marrow-derived mesenchymal stem cells. Journal of Biological Chemistry. 2008, 283: 20948-58. 10.1074/jbc.M800850200.CrossRefPubMedPubMedCentral
Metadata
Title
Myoblast sensitivity and fibroblast insensitivity to osteogenic conversion by BMP-2 correlates with the expression of Bmpr-1a
Authors
Renjing Liu
Samantha L Ginn
Monkol Lek
Kathryn N North
Ian E Alexander
David G Little
Aaron Schindeler
Publication date
01-12-2009
Publisher
BioMed Central
Published in
BMC Musculoskeletal Disorders / Issue 1/2009
Electronic ISSN: 1471-2474
DOI
https://doi.org/10.1186/1471-2474-10-51

Other articles of this Issue 1/2009

BMC Musculoskeletal Disorders 1/2009 Go to the issue

Research article

The effect of warm-up, static stretching and dynamic stretching on hamstring flexibility in previously injured subjects

Research article

Short-term effects of implemented high intensity shoulder elevation during computer work

Research article

Direction of the formation of anterior lumbar vertebral osteophytes

Research article

Presence of Mycoplasma fermentans in the bloodstream of Mexican patients with rheumatoid arthritis and IgM and IgG antibodies against whole microorganism

Research article

The association between back pain and trunk posture of workers in a special school for the severe handicaps

Research article

Total knee arthroplasty after high tibial osteotomy. A systematic review